Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal article

Original languageEnglish
JournalMetabolic Brain Disease
Issue number2
Pages (from-to)221-5
Number of pages5
StatePublished - Jun 2013

    Research areas

  • Amino Acids, Branched-Chain, Anti-Bacterial Agents, Disaccharides, Evidence-Based Medicine, Gastrointestinal Agents, Hepatic Encephalopathy, Humans, Lactulose, Rifamycins

See relations at Aarhus University Citationformats

ID: 69243239